Contact Us 联系我们
Contact Us 联系我们
Contact Us 联系我们

Proactive Investor interviews John Cullity

Race Oncology Non-Executive Director Dr. John Cullity speaks with Proactive Investors about the company’s cancer chemotherapy drug, Bisantrene.

Watch the video here.

© 2018 Race Oncology. Website By Multiplier